EWM
Edge Wealth Management Portfolio holdings
AUM
$519M
This Quarter Return
+2.14%
1 Year Return
+11.54%
3 Year Return
+47.62%
5 Year Return
+81.69%
10 Year Return
+180.5%
AUM
$393M
AUM Growth
+$393M
(+4.4%)
Cap. Flow
+$8.98M
Cap. Flow
% of AUM
2.29%
Top 10 Holdings %
Top 10 Hldgs %
37.12%
Holding
636
New
80
Increased
107
Reduced
94
Closed
56
Top Buys
| 1 |
General Mills
GIS
|
$8.59M |
| 2 |
Johnson & Johnson
JNJ
|
$2.56M |
| 3 |
Annaly Capital Management Series F
NLY.PRF
|
$2.26M |
| 4 |
AT&T
T
|
$1.6M |
| 5 |
Procter & Gamble
PG
|
$1.3M |
Top Sells
| 1 |
Bank of America
BAC
|
$7.34M |
| 2 |
IBM
IBM
|
$2.43M |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
$2.26M |
| 4 |
VanEck Gold Miners ETF
GDX
|
$2.25M |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
$1.25M |
Sector Composition
| 1 | Technology | 16.78% |
| 2 | Healthcare | 11.23% |
| 3 | Communication Services | 10.54% |
| 4 | Financials | 7.12% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Biogen
BIIB
$20.8B
| – | – |
-300
| Closed | -$82K |
|
602
ProShares Ultra NASDAQ Biotechnology
BIB
$55.7M
| – | – |
-200
| Closed | -$11K |
|
603
AstraZeneca
AZN
$255B
| – | – |
-1,043
| Closed | -$36K |
|
604
Arrowhead Research
ARWR
$3.84B
| – | – |
-5,000
| Closed | -$36K |
|
605
AquaBounty Technologies
AQB
$4.54M
| – | – |
0
-1
| -100% | -$1K |
|
606
Adverum Biotechnologies
ADVM
$68.2M
| – | – |
-250
| Closed | -$1K |
|
607
AbbVie
ABBV
$374B
| – | – |
-1,000
| Closed | -$95K |
|
608
Arbor Realty Trust
ABR
$2.28B
| – | – |
-49,836
| Closed | -$440K |
|